LSV Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.8M Buy
391,651
+210,992
+117% +$20M 0.06% 278
2026
Q2
$15.6M Buy
180,659
+164,259
+1,002% +$14.4M 0.03% 372
2026
Q1
$1.48M Hold
16,400
– – ﹤0.01% 607
2025
Q4
$1.48M Hold
16,400
– – ﹤0.01% 608
2025
Q3
$1.62M Sell
16,400
-16
-0.1% -$1.58K ﹤0.01% 601
2025
Q2
$1.5M Buy
16,416
+12,516
+321% +$1.21M ﹤0.01% 582
2025
Q1
$441K Hold
3,900
– – ﹤0.01% 697
2024
Q4
$412K Hold
3,900
– – ﹤0.01% 691
2024
Q3
$421K Hold
3,900
– – ﹤0.01% 723
2024
Q2
$423K Hold
3,900
– – ﹤0.01% 744
2024
Q1
$515K Buy
+3,900
New +$487K ﹤0.01% 730
2023
Q3
– Sell
-3,000
Closed -$437K – 898
2023
Q2
$437K Buy
+3,000
New +$408K ﹤0.01% 768
2016
Q1
– Sell
-210,326
Closed -$20.9M – 1046
2015
Q4
$20.9M Sell
210,326
-106,090
-34% -$10.4M 0.05% 281
2015
Q3
$28.9M Sell
316,416
-684,853
-68% -$68.7M 0.06% 233
2015
Q2
$106M Sell
1,001,269
-1,513,528
-60% -$167M 0.22% 126
2015
Q1
$287M Sell
2,514,797
-226,527
-8% -$25.8M 0.6% 51
2014
Q4
$302M Sell
2,741,324
-457,244
-14% -$48.2M 0.63% 48
2014
Q3
$312M Sell
3,198,568
-246,376
-7% -$24.2M 0.68% 43
2014
Q2
$347M Sell
3,444,944
-626,384
-15% -$61.1M 0.77% 35
2014
Q1
$374M Sell
4,071,328
-231,561
-5% -$21.3M 0.87% 28
2013
Q4
$389M Sell
4,302,889
-239,205
-5% -$20.7M 0.91% 24
2013
Q3
$362M Sell
4,542,094
-200,644
-4% -$15.8M 0.93% 17
2013
Q2
$345M Buy
+4,742,738
New +$355M 0.92% 20

Other funds holding ZBH

LSV Asset Management's ZBH Position: Q3 2026 in Review

LSV Asset Management increased its Zimmer Biomet (ZBH) stake by 117% in Q3 2026, buying an estimated $20M and bringing the position to 391,651 shares worth $34.8M. The position accounts for 0.06% of the portfolio, ranked #278.

LSV Asset Management first reported a position in ZBH in Q2 2013 and has held it in 23 quarters since. The position peaked at $389M in Q4 2013. 778 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • LSV Asset Management held 391,651 shares of Zimmer Biomet worth $34.8M as of Q3 2026.
  • LSV Asset Management bought 210,992 Zimmer Biomet shares in Q3 2026, an estimated $20M.
  • Zimmer Biomet made up 0.06% of LSV Asset Management's portfolio in Q3 2026, its #278 holding.
  • LSV Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 23 quarters since.
  • LSV Asset Management's Zimmer Biomet position peaked at $389M in Q4 2013.
  • 778 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on LSV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.